The PI3K/AKT/mTOR signaling pathway plays a critical role in uterine tumor biology, with immunohistochemical analyses demonstrating that nuclear phosphorylated Akt and mTOR expression levels increase progressively from benign ULM to intermediate STUMP to malignant ULMS [10]. The gene discussed is MTOR; the disease is tumor of uterus.